Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.54 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.47 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.46 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.46 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.44 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19127905 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL29508172 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL5084837 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL5204684 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL16884634 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL291932 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL835295 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL2825440 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL835150 | 1.00 | MAPT (0.55) | MAPTEPHX2CNR2KDM4EALDH1A1 | |
| SCHEMBL21376096 | 0.91 | MAPT (0.64) | MAPTEPHX2CNR2ALDH1A1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2242361-A2 | USE OF SURFACTANTS FOR MITIGATING DAMAGE TO PLANTS FROM PESTS | Bjarn, Llc (US) | 2010-10-27 | — | — | EP | disclosed |
| EP-2242369-A1 | USE OF BIO-DERIVED SURFACTANTS FOR MITIGATING DAMAGE TO PLANTS FROM PESTS | Bjarn, Llc (US) | 2010-10-27 | — | — | EP | disclosed |
| WO-2009091572-A2 | USE OF SURFACTANTS FOR MITIGATING DAMAGE TO PLANTS FROM PESTS | BJARN, LLC (US) | 2009-07-23 | — | — | WO | disclosed |
| US-20090186761-A1 | Use of bio-derived surfactants for mitigating damage to plants from pests | CLEARESO, LLC | 2009-07-23 | — | — | US | disclosed |
| WO-2009091564-A1 | USE OF BIO-DERIVED SURFACTANTS FOR MITIGATING DAMAGE TO PLANTS FROM PESTS | BJARN, LLC (US) | 2009-07-23 | — | — | WO | disclosed |
| US-20090186767-A1 | Use of surfactants for mitigating damage to plants from pests | CLEARESO, LLC | 2009-07-23 | — | — | US | disclosed |
| US-6903052-B2 | Nematicidal compositions and methods | DIVERGENCE, INC. (US) | 2005-06-07 | — | — | US | disclosed |
| US-6887900-B2 | Nematicidal compositions and methods | DIVERGENCE, INC. (US) | 2005-05-03 | — | — | US | disclosed |
| US-20030176402-A1 | Nematicidal compositions and methods | MONSANTO TECHNOLOGY LLC | 2003-09-18 | — | — | US | disclosed |
| US-20030166714-A1 | Nematicidal compositions and methods | MONSANTO TECHNOLOGY LLC | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186767-A1 | Use of surfactants for mitigating damage to plants from pests | FAAH, SGMS2, FASN | MAPT 2873/4885EPHX2 238/4885CNR2 355/4885 |
| US-20030166714-A1 | Nematicidal compositions and methods | SCD, FADS2, ELOVL3 | MAPT 4347/4885EPHX2 230/4885CNR2 229/4885 |
| US-20090186761-A1 | Use of bio-derived surfactants for mitigating damage to plants from pests | SGMS2, SGMS1, PHOSPHO1 | MAPT 2855/4885EPHX2 336/4885CNR2 436/4885 |
| US-20030176402-A1 | Nematicidal compositions and methods | FADS2, FASN, SCD | MAPT 4351/4885EPHX2 150/4885CNR2 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.